Active Surveillance
Active Surveillance for Prostate Cancer Active surveillance is a treatment strategy used for men with low-risk or some favorable […]
Development of an effective predictive screening tool for prostate cancer using the ClarityDX machine learning platform
The current prostate cancer (PCa) screen test, prostate-specific antigen (PSA), has a high sensitivity for PCa but low specificity for […]
Canadian Prostate Cancer Guide
The Canadian Cancer Survivor Network (CCSN) is a leader in patient participation in healthcare, with a mandate to educate the […]
Brad’s Story
I had been getting my PSA (Prostate Specific Antigen) tested for a few years along with a DRE (digital rectal […]
Prostate Cancer Centre’s Man Van Program
The Man Van® is a mobile Prostate Specific Antigen (PSA) blood testing facility. There are two vans, one used primarily […]
A LOSS OF TRUST
This true story is being shared at the request of the deceased. Tom Lucas retired as a captain with the […]
If something doesn’t seem right, it probably isn’t:
Our Story: G. was very athletic, jogging, cycling 7000K a year, ate all the right foods, stayed out of the […]
Prostate Specific Antigen (PSA) Testing
Prostate Specific Antigen (PSA) Testing What It Is, Why You Should Start Getting Tested, and When to Begin. Prostate-specific antigen […]
May 2023
Includes: Increase in active surveillance, Future Directions in Imaging, Physician’s Advice for defusing Patient Anger, Transgender Women Screening Disparity, and more!
March 2022
Includes: The PREVENT Study, Dr. Philip Barber bio, our first OPEN MIC NIGHT, PROpel Suggests Adding Olaparib to Abi-raterone Improves Outcomes, Risk vs. Benefit for Active Surveillance for Patients with Intermediate-Risk Disease, and more!